Cargando…
Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway
Background and aims: Saikosaponin d (SSd) has a steroidal structure and significant anti-inflammatory effects. The purpose of this study was to explore the mechanism underlying SSd’s inhibitory effects on liver fibrosis. Methods: Wild-type and estrogen receptor knockout (ERKO) mice were treated with...
Autores principales: | Zhang, Kehui, Lin, Liubing, Zhu, Yingying, Zhang, Na, Zhou, Meng’en, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174603/ https://www.ncbi.nlm.nih.gov/pubmed/35694250 http://dx.doi.org/10.3389/fphar.2022.894981 |
Ejemplares similares
-
Saikosaponin-d alleviates hepatic fibrosis through regulating GPER1/autophagy signaling
por: Chen, Yirong, et al.
Publicado: (2021) -
Inhibition of oxidative stress and NLRP3 inflammasome by Saikosaponin-d alleviates acute liver injury in carbon tetrachloride-induced hepatitis in mice
por: Chen, Yirong, et al.
Publicado: (2020) -
Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
por: Wang, Mei-Zi, et al.
Publicado: (2022) -
Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020) -
CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway
por: Jiang, Xuye, et al.
Publicado: (2021)